期刊文献+

血管紧张素Ⅱ及其受体1在实体肿瘤中的研究进展 被引量:3

下载PDF
导出
摘要 肾素-血管紧张素系统(renin-angiotensin system,RAS)是机体进化过程中高度保守的内分泌网络,血管紧张素Ⅱ(an-giotensinⅡ,AngⅡ)作为其中主要效应的分子,除了在心血管方面的作用外,在肿瘤的发生发展、血管形成和转移中的作用正越来越受到人们的重视。据大量实验研究表明血管紧张素Ⅱ参与肿瘤细胞的增殖、迁移、浸润和肿瘤血管形成,在肿瘤的发生发展中起着重要作用,为肿瘤治疗开辟了新的药物靶点。本文就血管紧张素Ⅱ及其受体1在实体肿瘤中的研究进展做一综述。
作者 黄玮 钟捷
出处 《肿瘤》 CAS CSCD 北大核心 2007年第2期162-163,166,共3页 Tumor
  • 相关文献

参考文献21

  • 1DESHAYES F,NAHMIAS C.Angiotensin receptors:a new role in cancer[J].Trends Endocrinol Metab,2005,16(7):293-299.
  • 2DINH D T,FRAUMAN A G,SOMERS G R,et al.Evidence for activation of the renin-angiotensin system in the human prostate:increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia[J].J Pathol,2002,196(2):213-219.
  • 3LAM K Y,LEUNG P S.Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours[J].Eur J Endocrinol,2002,146(4):567-572.
  • 4de PAEPE B,VERSTRAETEN V L,de POTTER C R,et al.Growth stimulatory angiotensin Ⅱ type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma[J].Histochem Cell Biol,2001,116(3):247-254.
  • 5TAKEDA H,KONDO S.Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression[J].Am J Pathol,2001,158(5):1633-1637.
  • 6FUJIMOTO Y,SASAKI T,TSUCHIDA A,et al.Angiotensin Ⅱ type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin ⅡI type 1 receptor antagonist[J].FEBS Lett,2001,495(3):197-200.
  • 7INO K,SHIBATA K,KAJIYAMA H,et al.Angiotensin Ⅱ type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival[J].Br J Cancer,2006,94(4):552-560.
  • 8AMAYA K,OHTA T,KITAGAWA H,et al.Angiotensin Ⅱ activates MAP kinase and NF-kappaB through angiotensin Ⅱ type I receptor in human pancreatic cancer cells[J].Int J Oncol,2004,25(4):849-856.
  • 9YASUMARU M,TSUJI S,TSUJII M,et al.Inhibition of angiotensin Ⅱ activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway[J].Cancer Res,2003,63(20):6726-6734.
  • 10DAS U N.Is angiotensin-Ⅱ an endogenous pro-inflammatory molecule[J].Med Sci Monit,2005,11(5):RA155-162.

同被引文献29

  • 1郑龙志,石铮.他汀类药物抗肿瘤作用的研究进展[J].医学综述,2006,12(10):605-607. 被引量:3
  • 2翟爱峰,李玛琳.非甾体类抗炎药抗肿瘤作用的研究进展[J].医学综述,2006,12(16):1000-1002. 被引量:5
  • 3廖艳丹,徐弘,韩庆,雷婕,张颖颖,王泽华.宫颈鳞癌组织与细胞系中血管紧张素Ⅱ-1型受体的表达及其临床意义[J].中华肿瘤杂志,2007,29(5):360-364. 被引量:9
  • 4章涛,余华荣,杨贵忠,刘颖菊,杨俊卿,蒋建新,周岐新.罗格列酮对人乳腺癌MDA-MB-231细胞的体外抗肿瘤作用[J].第四军医大学学报,2007,28(11):971-974. 被引量:7
  • 5Rousseau S, Houle F, Landry J, et al. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and eenmigration in human endothelial cells [J]. Onto gene, 1997, 15 (18): 2169-2175.
  • 6Levera F, Holed J, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer [J]. Lancet, 1998, 352 (9123) : 179 -184.
  • 7Suganuma T, Ino K, Shibata K, et al. Functional expression of the Angiotensin Ⅱ type Ⅰ receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination [J]. Clin Cancer Res,2005,11 (7) :2686 -2694.
  • 8Brown RE, Siegelmann DN, Zhang PL, et al. Morphop roteomic confirmation of an overexpressed angiotensin system in invasive breast carcinoma [ J ]. Ann Clime Lab Sci, 2006, 36(2) :225 -226.
  • 9Yoshiji H, Yoshii J. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells[J]. Int J Oncol, 2002, 20(6) :1227 - 1231.
  • 10Hash lmoto G, Inoki I, Fuji Y, et al. Matrixmetallop roteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165 [J]. J Biol Chem, 2002, 277 (39) : 36288 - 36295.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部